Glucocorticoid receptor polymorphisms influence muscle strength in Cushing's syndrome.
An important clinical feature of Cushing's syndrome (CS) is proximal muscle myopathy caused by glucocorticoid induced protein metabolism. However, inter-individual differences cannot be explained solely by the pure extent of hypercortisolemia. To evaluate the effects of glucocorticoid receptor (GR) polymorphisms (BclI, N363S, ER22/23EK and A3669G) which influence peripheral glucocorticoid sensitivity on muscular function in endogenous CS. 205 patients with proven endogenous CS (128 central, 77 adrenal) from 3 centers of the German Cushing's Registry and 125 subjects, in whom CS was ruled-out, were included. All subjects were assessed for grip strength (via hand grip dynamometer) and performed a chair rising test (CRT). DNA samples were obtained from peripheral blood leukocytes for GR genotyping. In patients with active CS, normalized handgrip strength of the dominant and non-dominant hand was higher in A3669G minor allele than in wildtype carriers (p=0.006, p=0.021 respectively). CS patients in remission and ruled-out CS showed no differences in handgrip strength regarding A3669G minor allele and wildtype carriers. Male CS patients harboring the ER22/23EK wildtype presented lower hand grip strength than minor allele carriers (p=0.049 dominant hand , p=0.027 non-dominant hand). The other polymorphisms did not influence handgrip strength. CRT showed no differences regarding GR polymorphisms carrier status. Handgrip strength seems to be more susceptible to hypercortisolism in A3669G wildtype than in A3669G minor allele carriers. This might partially explain the inter-individual differences of glucocorticoid-induced myopathy in patients with endogenous CS. ER22/23EK polymorphism seems to exert sex-specific differences.